FDA Inspection
Kelley-Ross & Associates, Inc. dba Kelley-Ross Compounding PharmacyKelley-Ross & Associates, Inc. dba Kelley-Ross Compounding Pharmacy – FDA Inspection, Sep 23, 2020
Record Details
This FDA Inspection record concerns Kelley-Ross & Associates, Inc. dba Kelley-Ross Compounding Pharmacy, with an inspection on September 23, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- September 23, 2020
- Product Type
- Drugs
View Company Profile
ID · cceaf20d-242f-48a8-922d-e7602f1d43de
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1129888
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
5- Disinfecting materials, aseptic processing area
- Improper gowning, contamination
- Cleanliness, ISO-classified areas
- Hazardous drugs, prevention of cross-contamination
- Air flow quality, higher classified area
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Kelley-Ross & Associates, Inc. dba Kelley-Ross Compounding Pharmacy
1| Date | Classification | Office | Project area |
|---|---|---|---|
| August 1, 2017 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Kelley-Ross & Associates, Inc. dba Kelley-Ross Compounding Pharmacy
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.